Cargando…
The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis
BACKGROUND: MIV-711 is a highly potent and selective cathepsin K inhibitor. The current article summarizes the therapeutic effects of MIV-711 on joint pathology in rabbits subjected to anterior cruciate ligament transection (ACLT), and the prophylactic effects on joint pathology in dogs subjected to...
Autores principales: | Lindström, Erik, Rizoska, Biljana, Tunblad, Karin, Edenius, Charlotte, Bendele, Alison M., Maul, Don, Larson, Michael, Shah, Neha, Yoder Otto, Valerie, Jerome, Chris, Grabowska, Urszula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845353/ https://www.ncbi.nlm.nih.gov/pubmed/29523155 http://dx.doi.org/10.1186/s12967-018-1425-7 |
Ejemplares similares
-
Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711
por: Lindström, Erik, et al.
Publicado: (2018) -
Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis pain
por: Nwosu, Lilian N., et al.
Publicado: (2018) -
Validation and recalibration of OxMIV in predicting violent behaviour in patients with schizophrenia spectrum disorders
por: Lamsma, Jelle, et al.
Publicado: (2022) -
A MIV-150/Zinc Acetate Gel Inhibits SHIV-RT Infection in Macaque Vaginal Explants
por: Barnable, Patrick, et al.
Publicado: (2014) -
Modified-dropless protocol (nil intraocular) for micro-incision vitrectomy surgery (MIVS): a retrospective pilot study
por: Garcia-O’Farrill, Noraliz, et al.
Publicado: (2023)